Detalles de la búsqueda
1.
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
Lancet
; 401(10370): 25-37, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36493791
2.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet
; 401(10370): 38-48, 2023 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495881
3.
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?
Ann Rheum Dis
; 83(1): 65-71, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607810
4.
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort.
Ann Rheum Dis
; 83(5): 589-598, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233104
5.
Goodbye to the term 'ankylosing spondylitis', hello 'axial spondyloarthritis': time to embrace the ASAS-defined nomenclature.
Ann Rheum Dis
; 83(5): 547-549, 2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38071514
6.
Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort.
Rheumatology (Oxford)
; 63(1): 85-92, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094184
7.
Performance of clinical, laboratory and imaging features for diagnosing spondyloarthritis-a systematic literature review and meta-analysis.
Rheumatology (Oxford)
; 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305346
8.
Treatment decisions in axial spondyloarthritis daily clinical practice are more than treat-to-target.
Rheumatology (Oxford)
; 63(1): 34-40, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37021937
9.
The impact of autoantibodies on the efficacy of biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis: meta-analysis of randomized controlled trials.
Rheumatology (Oxford)
; 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38366945
10.
Erosions on T1-Weighted Magnetic Resonance Imaging Versus Radiography of Sacroiliac Joints in Recent-Onset Axial Spondyloarthritis: 2-Year Data (EMBARK Trial and DESIR Cohort).
J Rheumatol
; 51(5): 462-471, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359938
11.
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients.
Rheumatol Int
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38597981
12.
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Ann Rheum Dis
; 82(1): 130-141, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36270657
13.
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.
Ann Rheum Dis
; 82(1): 142-152, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36261247
14.
Country-level socioeconomic status relates geographical latitude to the onset of RA: a worldwide cross-sectional analysis in the METEOR registry.
Ann Rheum Dis
; 82(8): 1018-1024, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37230737
15.
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis.
Ann Rheum Dis
; 82(4): 468-475, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526336
16.
Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.
Ann Rheum Dis
; 82(2): 212-216, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100350
17.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 95-106, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368906
18.
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 81-94, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410794
19.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 82(1): 107-118, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36376026
20.
ASAS consensus definition of early axial spondyloarthritis.
Ann Rheum Dis
; 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37321799